Arcadia Biosciences, Inc.
corporate_fare Company Profile
Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 23 items for RKDA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 18 rated 8 or above. Recent SEC coverage for RKDA spans 8-K, 10-Q, PRE 14A, 424B3.
Recent high-impact activity:
- Arcadia Stockholders Approve Reverse Split and New Equity Plan
- Second Nasdaq Delisting Notice Hits Arcadia Biosciences Over Equity Shortfall
- Arcadia Biosciences Q2 Net Loss Widens to $6.27M on Financing Valuation Loss
- Arcadia Biosciences Q2 Loss Widens to $6.27M; Going Concern and Nasdaq Delisting Risks Mount
- Arcadia Biosciences Q2 Loss Widens to $6.3M, but Zola Sales Inflect with July Revenue Topping $740K
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 342,847 shares in RKDA as of the October 15, 2026 settlement, a 286.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 3, 2026, 18.9% of RKDA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for RKDA, detected from its recent SEC filings · based on capital-structure filings through 2026-07-08.
Resale of 11.9 Million Shares Activated · Massive Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →